Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2012 Oct;12(5):291–296. doi: 10.1016/j.clml.2012.06.010

Table 1.

Patient Characteristics

MF
N=1713
Non-MF CTCL
N=1518
CBCL
N=1265
 Male 975 891 734
 Female 738 627 531
Race
 White 1240 1218 1096
 African American 228 152 64
 Asian/Pacific Islander 108 67 65
 Native American/other/unknown 137 81 40
Marital status
 Not married 488 433 363
 Married 806 776 720
 Unknown 419 309 182
Age
 Mean 57 60 63
 Median 58 62 64
Stage*
Low stage 1240 1012
High stage 211 258
Unstaged 262 248

MF-mycosis fungoides; CTCL-cutaneous T-cell lymphoma; CBCL-cutaneous B-cell lymphoma

*

For MF, low stage = T0–T2, and high stage = T3–T4. For non-MF CTCL, low stage = overall stage 0–II, high stage = overall stage III–IV. CBCL patients were not broken out into high and low staging.